In This Section

Newsroom

July 16, 2018
Temple-Led Research Calls into Question the Effectiveness of Inferior Vena Cava Filter Use in Patients Undergoing Catheter-Directed Thrombolysis for Deep Vein Thrombosis

Findings Suggest Practice Offered No In-Hospital Mortality Benefit and Was Associated with Increased Procedure-Related Hematomas, Increased Length of Stay and Higher Charges
- VIEW STORY
July 02, 2018
Temple University Hospital Offering First FDA-Approved Minimally Invasive Bronchoscopic Treatment for Emphysema

The U.S. Food and Drug Administration has granted pre-market approval under its breakthrough devices designation to the Zephyr® EBV® to treat breathing difficulty associated with severe emphysema.
- VIEW STORY
June 12, 2018
Temple Scientists Eradicate Cancer Cells Through Dual Targeting of DNA Repair Mechanisms

New research by scientists at the Lewis Katz School of Medicine at Temple University (LKSOM) may help eradicate cancer cells.
- VIEW STORY
June 08, 2018
Temple Researchers Successfully Reverse Cognitive Impairments in Mice with Dementia

Researchers at the Lewis Katz School of Medicine at Temple University (LKSOM) show, for the first time in an animal model, that tau pathology – the second-most important lesion in the brain in patients with Alzheimer's disease – can be reversed by a drug.
- VIEW STORY
May 23, 2018
Congratulations, Class of 2018!

Pride, satisfaction and outright joy swelled at different turns of the 116th commencement for the Lewis Katz School of Medicine (LKSOM) at Temple University, held this year at the Kimmel Center for the Performing Arts in Center City. But even more prominent was the encouragement the various speakers offered, telling the graduates that there is still much work to be done.
- VIEW STORY
May 22, 2018
Temple Researchers Lead Landmark Trial Demonstrating Effectiveness of Minimally Invasive Treatment for Emphysema

Surgery to remove small portions of damaged lung tissue helps some patients but is invasive and risky. Now, an effective, but safer option – the Zephyr® Endobronchial Valve (Zephyr® EBV®) – may provide an alternative.
- VIEW STORY
May 18, 2018
Temple’s Dr. Larry Kaiser Named a “Great Leader in Healthcare” by Becker’s Hospital Review

Larry R. Kaiser, MD, FACS has been named by Becker’s Hospital Review to its list of “100 Great Leaders in Healthcare” for 2018.
- VIEW STORY
May 16, 2018
Elevated Homocysteine Identified as Metabolic Risk Factor for Neurodegenerative Diseases, Scientists at Temple Report

The amino acid homocysteine occurs naturally in the human body, generated as a byproduct of methionine metabolism. Genetic diseases or an imbalanced diet, with too much red meat or deficiencies in B vitamins and folic acid, however, can lead to high homocysteine levels, a condition known as hyperhomocysteinemia.
- VIEW STORY

Newsroom

Pages